ProPublica

PODCAST: One Professor’s Discovery About Speaking Truth to Power

PODCAST: One Professor’s Discovery About Speaking Truth to Power
In his new book, Originals: How Non-Conformists Move the World, Adam Grant examines the circumstances that give rise to truly original thinkers and groundbreaking ideas. Throughout Originals, the Wharton School of Business professor shares stories from the fields of business, politics and sports, and his chapter exploring the psychology of speaking truth to power – whether it be federal whistleblowers, or a middle-level employee with an innovative idea – holds several lessons for investigative journalists and the people on which they report. For this week’s podcast, ProPublica reporter David Epstein talks with Grant about takeaways from the book.
origin Author: 
origin Blog: 

Bad Grandpa: The Ugly Forefather of New York’s Affordable Housing Debacles

Bad Grandpa: The Ugly Forefather of New York’s Affordable Housing Debacles
Thus began a 2001 article by Eric Lipton in The New York Times. It must come as no surprise to the reader that almost 15 years later, ProPublica detailed how New York City failed to police expensive tax subsidies it gave out to developers in exchange for limiting rent increases and including a modest number of affordable apartments in projects.
origin Author: 
origin Blog: 

ProPublica Partners with Yelp to Bring Big Data to Bear on Healthcare

ProPublica Partners with Yelp to Bring Big Data to Bear on Healthcare
Yelp may be best known for its restaurant and nightclub reviews, but the site’s seeds were actually planted when CEO Jeremy Stoppelman had trouble finding recommendations for a local doctor. Health providers now account for a rapidly growing six percent of Yelp’s reviewed businesses. Thanks to a new partnership with ProPublica, the site’s star ratings system is being supplemented with objective healthcare data.
origin Author: 
origin Blog: 

FDA Let Drugs Approved on Fraudulent Research Stay on the Market

FDA Let Drugs Approved on Fraudulent Research Stay on the Market
About 100 drugs, including sophisticated chemotherapy compounds and addictive prescription painkillers, had been approved for sale in the United States at least in part on the strength of Cetero Houston's tainted tests.
origin Author: 
origin Blog: 

Westchester County Could Lose Millions for Fair Housing Failures

Westchester County Could Lose Millions for Fair Housing Failures
After more than three years of clashing with the federal government, Westchester County may finally have to pay a price for its failures to comply with a residential desegregation court order: $7.4 million.
origin Author: 
origin Blog: 

When Harm in the Hospital Follows You Home

When Harm in the Hospital Follows You Home
A slip of the scalpel, an invisible microbe, a minute miscalculation. It's estimated that something goes wrong for more than one million people per year during a visit to the hospital. Some patients experience a full physical recovery. Some are never fully healed.
origin Author: 
origin Blog: 

Dollars for Docs Mints a Millionaire

Dollars for Docs Mints a Millionaire
New data show drug makers’ payments to hundreds of thousands of doctors, and some have made well over $500,000.
origin Author: 
origin Blog: 

What Researchers Learned About Gun Violence Before Congress Killed Funding

What Researchers Learned About Gun Violence Before Congress Killed Funding
ProPublica interviews Dr. Mark Rosenberg, who led the CDC's gun violence research in the '90s when he was the director of the National Center for Injury Prevention and Control.
origin Author: 
origin Blog: 

Four Disturbing Questions About the Mumbai Terror Attack

Four Disturbing Questions About the Mumbai Terror Attack
The 35-year prison sentence imposed on David Coleman Headley, a terrorist scout and Pakistani spy convicted in the 2008 Mumbai attacks, has closed the U.S. chapter of a case with explosive international implications.​
origin Author: 
origin Blog: 

Big Corporations Put Up Seed Funding for Republican Dark Money Group

Big Corporations Put Up Seed Funding for Republican Dark Money Group
A records request by ProPublica to the IRS turned up a list of the original funders of the group: Exxon, Pfizer, Time Warner, and other corporations put up at least 85 percent of the $1.3 million the foundation raised in the first year and a half of its existence, starting in 2003.
origin Author: 
origin Blog: 

Pages